The HIV diagnostics market encompasses diagnostic screening and confirmatory tests for HIV-1, 2 and group O incidence testing. These tests have primary applications to screen and differentiate between the various groups and subtypes of human immunodeficiency virus.
This report aims to provide a comprehensive presentation of the global market for HIV Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Diagnostics. This report contains market size and forecasts of HIV Diagnostics in global, including the following market information:
Global HIV Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global HIV Diagnostics market was valued at US$ 2712.5 million in 2022 and is projected to reach US$ 4690.9 million by 2029, at a CAGR of 8.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Owing to the technological development of disease diagnostic tests and the anticipated development and commercialization of novel, regulatory authorities approved POC and rapid CD4, p24 antigen and EID tests, it is expected that all the major regional market segments will witness an increase in market demand over the forecast period.
We surveyed the HIV Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HIV Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global HIV Diagnostics Market Segment Percentages, by Type, 2022 (%)
Consumables
Assay, Kits and Reagents
Other Consumables
Instruments
Software and Services
Global HIV Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global HIV Diagnostics Market Segment Percentages, by Application, 2022 (%)
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
Global HIV Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global HIV Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies HIV Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies HIV Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Abbott Healthcare
Abbvie Inc.
Brsitol-Myers Squibb
Janssen Therapeutics
Gilead Sciences
Merck & Co. Inc
VIIV Healthcare
BD Biosciences
Beckman Coulter
Partec
Sysmex
Apogee Flow Systems
PointCare Technologies Inc.
Zyomyx Inc.
Mylan inc.
Roche Diagnostics
Siemens Healthcare
Qiagen
BioMerieux
Outline of Major Chapters:
Chapter 1: Introduces the definition of HIV Diagnostics, market overview.
Chapter 2: Global HIV Diagnostics market size in revenue.
Chapter 3: Detailed analysis of HIV Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of HIV Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 HIV Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global HIV Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global HIV Diagnostics Overall Market Size
2.1 Global HIV Diagnostics Market Size: 2022 VS 2029
2.2 Global HIV Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top HIV Diagnostics Players in Global Market
3.2 Top Global HIV Diagnostics Companies Ranked by Revenue
3.3 Global HIV Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 HIV Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies HIV Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 HIV Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 HIV Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 HIV Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global HIV Diagnostics Market Size Markets, 2022 & 2029
4.1.2 Consumables
4.1.3 Assay, Kits and Reagents
4.1.4 Other Consumables
4.1.5 Instruments
4.1.6 Software and Services
4.2 By Type - Global HIV Diagnostics Revenue & Forecasts
4.2.1 By Type - Global HIV Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global HIV Diagnostics Revenue, 2024-2029
4.2.3 By Type - Global HIV Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global HIV Diagnostics Market Size, 2022 & 2029
5.1.2 Antibody Tests
5.1.3 Viral Load Tests
5.1.4 CD4 Tests
5.1.5 Tests for Early Infant Diagnosis
5.1.6 Tests for Viral Identification
5.2 By Application - Global HIV Diagnostics Revenue & Forecasts
5.2.1 By Application - Global HIV Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global HIV Diagnostics Revenue, 2024-2029
5.2.3 By Application - Global HIV Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global HIV Diagnostics Market Size, 2022 & 2029
6.2 By Region - Global HIV Diagnostics Revenue & Forecasts
6.2.1 By Region - Global HIV Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global HIV Diagnostics Revenue, 2024-2029
6.2.3 By Region - Global HIV Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America HIV Diagnostics Revenue, 2018-2029
6.3.2 US HIV Diagnostics Market Size, 2018-2029
6.3.3 Canada HIV Diagnostics Market Size, 2018-2029
6.3.4 Mexico HIV Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe HIV Diagnostics Revenue, 2018-2029
6.4.2 Germany HIV Diagnostics Market Size, 2018-2029
6.4.3 France HIV Diagnostics Market Size, 2018-2029
6.4.4 U.K. HIV Diagnostics Market Size, 2018-2029
6.4.5 Italy HIV Diagnostics Market Size, 2018-2029
6.4.6 Russia HIV Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries HIV Diagnostics Market Size, 2018-2029
6.4.8 Benelux HIV Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia HIV Diagnostics Revenue, 2018-2029
6.5.2 China HIV Diagnostics Market Size, 2018-2029
6.5.3 Japan HIV Diagnostics Market Size, 2018-2029
6.5.4 South Korea HIV Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia HIV Diagnostics Market Size, 2018-2029
6.5.6 India HIV Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America HIV Diagnostics Revenue, 2018-2029
6.6.2 Brazil HIV Diagnostics Market Size, 2018-2029
6.6.3 Argentina HIV Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa HIV Diagnostics Revenue, 2018-2029
6.7.2 Turkey HIV Diagnostics Market Size, 2018-2029
6.7.3 Israel HIV Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia HIV Diagnostics Market Size, 2018-2029
6.7.5 UAE HIV Diagnostics Market Size, 2018-2029
7 HIV Diagnostics Companies Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott HIV Diagnostics Major Product Offerings
7.1.4 Abbott HIV Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Abbott Key News & Latest Developments
7.2 Abbott Healthcare
7.2.1 Abbott Healthcare Company Summary
7.2.2 Abbott Healthcare Business Overview
7.2.3 Abbott Healthcare HIV Diagnostics Major Product Offerings
7.2.4 Abbott Healthcare HIV Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Abbott Healthcare Key News & Latest Developments
7.3 Abbvie Inc.
7.3.1 Abbvie Inc. Company Summary
7.3.2 Abbvie Inc. Business Overview
7.3.3 Abbvie Inc. HIV Diagnostics Major Product Offerings
7.3.4 Abbvie Inc. HIV Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Abbvie Inc. Key News & Latest Developments
7.4 Brsitol-Myers Squibb
7.4.1 Brsitol-Myers Squibb Company Summary
7.4.2 Brsitol-Myers Squibb Business Overview
7.4.3 Brsitol-Myers Squibb HIV Diagnostics Major Product Offerings
7.4.4 Brsitol-Myers Squibb HIV Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Brsitol-Myers Squibb Key News & Latest Developments
7.5 Janssen Therapeutics
7.5.1 Janssen Therapeutics Company Summary
7.5.2 Janssen Therapeutics Business Overview
7.5.3 Janssen Therapeutics HIV Diagnostics Major Product Offerings
7.5.4 Janssen Therapeutics HIV Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Janssen Therapeutics Key News & Latest Developments
7.6 Gilead Sciences
7.6.1 Gilead Sciences Company Summary
7.6.2 Gilead Sciences Business Overview
7.6.3 Gilead Sciences HIV Diagnostics Major Product Offerings
7.6.4 Gilead Sciences HIV Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Gilead Sciences Key News & Latest Developments
7.7 Merck & Co. Inc
7.7.1 Merck & Co. Inc Company Summary
7.7.2 Merck & Co. Inc Business Overview
7.7.3 Merck & Co. Inc HIV Diagnostics Major Product Offerings
7.7.4 Merck & Co. Inc HIV Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Merck & Co. Inc Key News & Latest Developments
7.8 VIIV Healthcare
7.8.1 VIIV Healthcare Company Summary
7.8.2 VIIV Healthcare Business Overview
7.8.3 VIIV Healthcare HIV Diagnostics Major Product Offerings
7.8.4 VIIV Healthcare HIV Diagnostics Revenue in Global Market (2018-2023)
7.8.5 VIIV Healthcare Key News & Latest Developments
7.9 BD Biosciences
7.9.1 BD Biosciences Company Summary
7.9.2 BD Biosciences Business Overview
7.9.3 BD Biosciences HIV Diagnostics Major Product Offerings
7.9.4 BD Biosciences HIV Diagnostics Revenue in Global Market (2018-2023)
7.9.5 BD Biosciences Key News & Latest Developments
7.10 Beckman Coulter
7.10.1 Beckman Coulter Company Summary
7.10.2 Beckman Coulter Business Overview
7.10.3 Beckman Coulter HIV Diagnostics Major Product Offerings
7.10.4 Beckman Coulter HIV Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Beckman Coulter Key News & Latest Developments
7.11 Partec
7.11.1 Partec Company Summary
7.11.2 Partec Business Overview
7.11.3 Partec HIV Diagnostics Major Product Offerings
7.11.4 Partec HIV Diagnostics Revenue in Global Market (2018-2023)
7.11.5 Partec Key News & Latest Developments
7.12 Sysmex
7.12.1 Sysmex Company Summary
7.12.2 Sysmex Business Overview
7.12.3 Sysmex HIV Diagnostics Major Product Offerings
7.12.4 Sysmex HIV Diagnostics Revenue in Global Market (2018-2023)
7.12.5 Sysmex Key News & Latest Developments
7.13 Apogee Flow Systems
7.13.1 Apogee Flow Systems Company Summary
7.13.2 Apogee Flow Systems Business Overview
7.13.3 Apogee Flow Systems HIV Diagnostics Major Product Offerings
7.13.4 Apogee Flow Systems HIV Diagnostics Revenue in Global Market (2018-2023)
7.13.5 Apogee Flow Systems Key News & Latest Developments
7.14 PointCare Technologies Inc.
7.14.1 PointCare Technologies Inc. Company Summary
7.14.2 PointCare Technologies Inc. Business Overview
7.14.3 PointCare Technologies Inc. HIV Diagnostics Major Product Offerings
7.14.4 PointCare Technologies Inc. HIV Diagnostics Revenue in Global Market (2018-2023)
7.14.5 PointCare Technologies Inc. Key News & Latest Developments
7.15 Zyomyx Inc.
7.15.1 Zyomyx Inc. Company Summary
7.15.2 Zyomyx Inc. Business Overview
7.15.3 Zyomyx Inc. HIV Diagnostics Major Product Offerings
7.15.4 Zyomyx Inc. HIV Diagnostics Revenue in Global Market (2018-2023)
7.15.5 Zyomyx Inc. Key News & Latest Developments
7.16 Mylan inc.
7.16.1 Mylan inc. Company Summary
7.16.2 Mylan inc. Business Overview
7.16.3 Mylan inc. HIV Diagnostics Major Product Offerings
7.16.4 Mylan inc. HIV Diagnostics Revenue in Global Market (2018-2023)
7.16.5 Mylan inc. Key News & Latest Developments
7.17 Roche Diagnostics
7.17.1 Roche Diagnostics Company Summary
7.17.2 Roche Diagnostics Business Overview
7.17.3 Roche Diagnostics HIV Diagnostics Major Product Offerings
7.17.4 Roche Diagnostics HIV Diagnostics Revenue in Global Market (2018-2023)
7.17.5 Roche Diagnostics Key News & Latest Developments
7.18 Siemens Healthcare
7.18.1 Siemens Healthcare Company Summary
7.18.2 Siemens Healthcare Business Overview
7.18.3 Siemens Healthcare HIV Diagnostics Major Product Offerings
7.18.4 Siemens Healthcare HIV Diagnostics Revenue in Global Market (2018-2023)
7.18.5 Siemens Healthcare Key News & Latest Developments
7.19 Qiagen
7.19.1 Qiagen Company Summary
7.19.2 Qiagen Business Overview
7.19.3 Qiagen HIV Diagnostics Major Product Offerings
7.19.4 Qiagen HIV Diagnostics Revenue in Global Market (2018-2023)
7.19.5 Qiagen Key News & Latest Developments
7.20 BioMerieux
7.20.1 BioMerieux Company Summary
7.20.2 BioMerieux Business Overview
7.20.3 BioMerieux HIV Diagnostics Major Product Offerings
7.20.4 BioMerieux HIV Diagnostics Revenue in Global Market (2018-2023)
7.20.5 BioMerieux Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. HIV Diagnostics Market Opportunities & Trends in Global Market
Table 2. HIV Diagnostics Market Drivers in Global Market
Table 3. HIV Diagnostics Market Restraints in Global Market
Table 4. Key Players of HIV Diagnostics in Global Market
Table 5. Top HIV Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global HIV Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global HIV Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies HIV Diagnostics Product Type
Table 9. List of Global Tier 1 HIV Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 HIV Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global HIV Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - HIV Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - HIV Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global HIV Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - HIV Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - HIV Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global HIV Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global HIV Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global HIV Diagnostics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America HIV Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America HIV Diagnostics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe HIV Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe HIV Diagnostics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia HIV Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia HIV Diagnostics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America HIV Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America HIV Diagnostics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa HIV Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa HIV Diagnostics Revenue, (US$, Mn), 2024-2029
Table 30. Abbott Company Summary
Table 31. Abbott HIV Diagnostics Product Offerings
Table 32. Abbott HIV Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Key News & Latest Developments
Table 34. Abbott Healthcare Company Summary
Table 35. Abbott Healthcare HIV Diagnostics Product Offerings
Table 36. Abbott Healthcare HIV Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Abbott Healthcare Key News & Latest Developments
Table 38. Abbvie Inc. Company Summary
Table 39. Abbvie Inc. HIV Diagnostics Product Offerings
Table 40. Abbvie Inc. HIV Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Abbvie Inc. Key News & Latest Developments
Table 42. Brsitol-Myers Squibb Company Summary
Table 43. Brsitol-Myers Squibb HIV Diagnostics Product Offerings
Table 44. Brsitol-Myers Squibb HIV Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Brsitol-Myers Squibb Key News & Latest Developments
Table 46. Janssen Therapeutics Company Summary
Table 47. Janssen Therapeutics HIV Diagnostics Product Offerings
Table 48. Janssen Therapeutics HIV Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Janssen Therapeutics Key News & Latest Developments
Table 50. Gilead Sciences Company Summary
Table 51. Gilead Sciences HIV Diagnostics Product Offerings
Table 52. Gilead Sciences HIV Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Gilead Sciences Key News & Latest Developments
Table 54. Merck & Co. Inc Company Summary
Table 55. Merck & Co. Inc HIV Diagnostics Product Offerings
Table 56. Merck & Co. Inc HIV Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Merck & Co. Inc Key News & Latest Developments
Table 58. VIIV Healthcare Company Summary
Table 59. VIIV Healthcare HIV Diagnostics Product Offerings
Table 60. VIIV Healthcare HIV Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. VIIV Healthcare Key News & Latest Developments
Table 62. BD Biosciences Company Summary
Table 63. BD Biosciences HIV Diagnostics Product Offerings
Table 64. BD Biosciences HIV Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. BD Biosciences Key News & Latest Developments
Table 66. Beckman Coulter Company Summary
Table 67. Beckman Coulter HIV Diagnostics Product Offerings
Table 68. Beckman Coulter HIV Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Beckman Coulter Key News & Latest Developments
Table 70. Partec Company Summary
Table 71. Partec HIV Diagnostics Product Offerings
Table 72. Partec HIV Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 73. Partec Key News & Latest Developments
Table 74. Sysmex Company Summary
Table 75. Sysmex HIV Diagnostics Product Offerings
Table 76. Sysmex HIV Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 77. Sysmex Key News & Latest Developments
Table 78. Apogee Flow Systems Company Summary
Table 79. Apogee Flow Systems HIV Diagnostics Product Offerings
Table 80. Apogee Flow Systems HIV Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 81. Apogee Flow Systems Key News & Latest Developments
Table 82. PointCare Technologies Inc. Company Summary
Table 83. PointCare Technologies Inc. HIV Diagnostics Product Offerings
Table 84. PointCare Technologies Inc. HIV Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 85. PointCare Technologies Inc. Key News & Latest Developments
Table 86. Zyomyx Inc. Company Summary
Table 87. Zyomyx Inc. HIV Diagnostics Product Offerings
Table 88. Zyomyx Inc. HIV Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 89. Zyomyx Inc. Key News & Latest Developments
Table 90. Mylan inc. Company Summary
Table 91. Mylan inc. HIV Diagnostics Product Offerings
Table 92. Mylan inc. HIV Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 93. Mylan inc. Key News & Latest Developments
Table 94. Roche Diagnostics Company Summary
Table 95. Roche Diagnostics HIV Diagnostics Product Offerings
Table 96. Roche Diagnostics HIV Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 97. Roche Diagnostics Key News & Latest Developments
Table 98. Siemens Healthcare Company Summary
Table 99. Siemens Healthcare HIV Diagnostics Product Offerings
Table 100. Siemens Healthcare HIV Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 101. Siemens Healthcare Key News & Latest Developments
Table 102. Qiagen Company Summary
Table 103. Qiagen HIV Diagnostics Product Offerings
Table 104. Qiagen HIV Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 105. Qiagen Key News & Latest Developments
Table 106. BioMerieux Company Summary
Table 107. BioMerieux HIV Diagnostics Product Offerings
Table 108. BioMerieux HIV Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 109. BioMerieux Key News & Latest Developments
List of Figures
Figure 1. HIV Diagnostics Segment by Type in 2022
Figure 2. HIV Diagnostics Segment by Application in 2022
Figure 3. Global HIV Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global HIV Diagnostics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global HIV Diagnostics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by HIV Diagnostics Revenue in 2022
Figure 8. By Type - Global HIV Diagnostics Revenue Market Share, 2018-2029
Figure 9. By Application - Global HIV Diagnostics Revenue Market Share, 2018-2029
Figure 10. By Type - Global HIV Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global HIV Diagnostics Revenue Market Share, 2018-2029
Figure 12. By Application - Global HIV Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global HIV Diagnostics Revenue Market Share, 2018-2029
Figure 14. By Region - Global HIV Diagnostics Revenue Market Share, 2018-2029
Figure 15. By Country - North America HIV Diagnostics Revenue Market Share, 2018-2029
Figure 16. US HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe HIV Diagnostics Revenue Market Share, 2018-2029
Figure 20. Germany HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 21. France HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia HIV Diagnostics Revenue Market Share, 2018-2029
Figure 28. China HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 32. India HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America HIV Diagnostics Revenue Market Share, 2018-2029
Figure 34. Brazil HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa HIV Diagnostics Revenue Market Share, 2018-2029
Figure 37. Turkey HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE HIV Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 41. Abbott HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Abbott Healthcare HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Abbvie Inc. HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Brsitol-Myers Squibb HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Janssen Therapeutics HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Gilead Sciences HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Merck & Co. Inc HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. VIIV Healthcare HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. BD Biosciences HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Beckman Coulter HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Partec HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Sysmex HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Apogee Flow Systems HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. PointCare Technologies Inc. HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Zyomyx Inc. HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Mylan inc. HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Roche Diagnostics HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Siemens Healthcare HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Qiagen HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. BioMerieux HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
